Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04535089Phase 2Completed
A Phase 2 trial of dexmedetomidine, Lidocaine Hydrochloride Injection, without epinephrine in pain, sponsored by Zagazig University. Started Oct 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04535089.